Sartorius Aktiengesellschaft (SUVPF) Stock Price, News & Analysis

Company Overview

Sartorius Aktiengesellschaft is a Germany-based life science company that develops and supplies technologies used by biopharmaceutical manufacturers, laboratories and research institutions. Founded in 1870 by Florenz Sartorius in Göttingen, Germany, the company has evolved from a manufacturer of precision balances into a global provider of laboratory and bioprocessing solutions.

Its Bioprocess Solutions business provides equipment, consumables and services used in the development and production of biopharmaceuticals, including single-use manufacturing systems, bioreactors, filtration and purification technologies, fluid-management products, cell culture solutions and process-monitoring tools. These products support applications ranging from early-stage research to commercial manufacturing of vaccines, antibodies and other biologic medicines.

Through its laboratory-focused activities, Sartorius offers instruments and consumables such as laboratory balances, pipetting products, lab filtration systems, water purification equipment, cell analysis technologies and related software and services. The company serves pharmaceutical and biotechnology companies, academic and research institutions, healthcare organizations and other laboratories across international markets, with operations and customers spanning Europe, the Americas and Asia-Pacific.

Key Stats

• Today's Range: $275.96 to $275.96
• 50-Day Range: $256.25 to $275.96
• 52-Week Range: $226.38 to $312.93
• Volume: N/A
• Average Volume: 187 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 9/29/2026
• Next Earnings (Estimated): 10/22/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SUVPF
• CIK: N/A
• Web: www.sartorius.com
• Phone: 495513080
• Fax: N/A
• Employees: 14,614
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A